Abstract
Hyperandrogenism is a common pathology in women, with the main physical manifestations including hirsutism and acne. Etiologies include polycystic ovarian syndrome (PCOS), idiopathic hirsutism, classical and nonclassical congenital adrenal hyperplasia (CAH), ovarian and adrenal tumors, Cushing’s disease, and certain medications. The severity of the hirsutism will vary among patients, but treatment should be administered to those who desire it, even if their hirsutism is not severe. Treatment methods include weight reduction, hair removal, oral contraceptive pills, and antiandrogen medications including spironolactone, finasteride, cyproterone acetate, flutamide, and eflornithine. Treatments for acne include topical retinoids, topical antimicrobials (benzoyl peroxide), topical antibiotics (erythromycin, clindamycin, sulfacetamide, dapsone), or oral isotretinoin.
References
Adams J, Polson DW, Franks S. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. Br Med J. 1986;293(6543):355–9.
Azziz R, Carmina E, Sawaya ME. Idiopathic hirsutism. Endocr Rev. 2000;21(4):347–62.
Barbieri RL. Treatment of hirsutism. Wolters Kluwer Health; 2013. Available from: Web 2 Mar 2015. http://www.uptodate.com/contents/treatment-of-hirsutism?source=search_result&search=treatment%2Bof%2Bhirsutism&selectedTitle=1~128
Barbieri RL, Ehrmann DA. Evaluation of premenopausal women with hirsutism. Wolters Kluwer Health; 2013a. Web 24 Nov 2014. http://www.uptodate.com/contents/evaluation-of-premenopausal-women-with-hirsutism
Barbieri RL, Ehrmann DA. Pathogenesis and causes of hirsutism. Wolters Kluwer Health; 2013b. Available from: Web 27 Feb 2015. http://www.uptodate.com/contents/pathogenesis-and-causes-of-hirsutism
Carr B, Breslau N, et al. Oral contraceptive pill, GnRH agonist, or use in combination for treatment of hirsutism. J Clin Endocrinol Metab. 1995;60(4):1169.
Cosma M, Swiglo BA, Flynn DN, et al. Clinical review: insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials. J Clin Endocrinol Metab. 2008;93:1135.
Demidov VN, Lipatenkova J, Vikhareva O, Van Holsbeke C, Timmerman D, Valentin L. Imaging of gynecological disease (2): clinical and ultrasound characteristics of Sertoli cell tumors, Sertoli-Leydig cell tumors and Leydig cell tumors. Ultrasound Obstet Gynecol. 2008;31(1):85–91.
Dorn C, Mouillet JF, Yan X, Ou Q, Sadovsky Y. Insulin enhances the transcription of luteinizing hormone-beta gene. Am J Obstet Gynecol. 2004;191(1):132–7.
Goljan EF, Sloka KI. Endocrine disorders rapid review laboratory testing in clinical medicine. Philadelphia: Mosby Elsevier; 2007. p. 365–70.
Grabber E. Treatment of acne vulgaris. Wolters Kluwer Health; 2015. Available from: Web 27 Mar 2015. http://www.uptodate.com/contents/treatment-of-acne-vulgaris?source=search_result&search=treatment%2Bof%2Bacne&selectedTitle=1~150#H1
Lebovic DI, Gordon JD, Taylor RN. Polycystic ovarian syndrome. In: Reproductive endocrinology and infertility: handbook for clinicians. Arlington: Scrub Hill; 2013a. p. 194–6.
Lebovic DI, Gordon JD, Taylor RN. Polycystic ovarian syndrome. In: Reproductive endocrinology and infertility: handbook for clinicians. Arlington: Scrub Hill; 2013b. p. 186–9.
Lebovic DI, Gordon JD, Taylor RN. Polycystic ovarian syndrome. In: Reproductive endocrinology and infertility: handbook for clinicians. Arlington: Scrub Hill; 2013c. p. 197–9.
Miller KK, Rosner W, Lee H, et al. Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab. 2004;89(2):525–33.
Phipps WR. Polycystic ovary syndrome and ovulation induction. Obstet Gynecol Clin North Am. 2001;28(1):165.
Rotterdam EA-SPcwg. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41–7.
Schorge JO, Williams JW. Polycystic ovarian syndrome and hyperandrogenism: introduction. In: Williams gynecology. New York: McGraw-Hill Medical; 2008a. p. 779–91.
Schorge JO, Williams JW. Polycystic ovarian syndrome and hyperandrogenism: introduction. In: Williams gynecology. New York: McGraw-Hill Medical; 2008b. p. 785.
Speiser PW. Congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Endocrinol Metab Clin North Am. 2001;30(1):31–59, vi.
Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038–49.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this entry
Cite this entry
Evans, M.B., Hill, M. (2016). Hyperandrogenism: Acne and Hirsutism. In: Shoupe, D. (eds) Handbook of Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-17002-2_40-2
Download citation
DOI: https://doi.org/10.1007/978-3-319-17002-2_40-2
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-17002-2
eBook Packages: Springer Reference MedicineReference Module Medicine
Publish with us
Chapter history
-
Latest
Hyperandrogenism: Acne and Hirsutism- Published:
- 14 May 2016
DOI: https://doi.org/10.1007/978-3-319-17002-2_40-2
-
Original
Hyperandrogenism: Acne and Hirsutism- Published:
- 05 February 2016
DOI: https://doi.org/10.1007/978-3-319-17002-2_40-1